EYETECH PHARMACEUTICALS

eyetech-pharmaceuticals-logo

Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye. The company conducted research and development into wet age-related macular degeneration diseases, which was seen as a breakthrough in the field. Valeant Pharmaceuticals International acquired Eyetech for US$22 million in 2012.

#SimilarOrganizations #People #Financial #Website #More

EYETECH PHARMACEUTICALS

Industry:
Biopharma Biotechnology Medical

Founded:
1997-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.eyetk.com

Total Employee:
251+

Status:
Closed

Total Funding:
108.5 M USD

Technology used in webpage:
SPF SAKURA Internet


Similar Organizations

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.


Current Advisors List

srinivas-akkaraju_image

Srinivas Akkaraju Board Member @ Eyetech Pharmaceuticals
Board_member

marc-galletti_image

Marc Galletti Investor @ Eyetech Pharmaceuticals
Board_member

Current Employees Featured

not_available_image

Henry Simon
Henry Simon Chairman @ Eyetech Pharmaceuticals
Chairman

samir-patel_image

Samir Patel
Samir Patel Co-founder, Chief Medical Officer, Boards of Directors @ Eyetech Pharmaceuticals
Co-founder, Chief Medical Officer, Boards of Directors

Founder


anthony-p-adamis_image

Anthony P. Adamis

david-guyer_image

David Guyer

not_available_image

Marty Glick

samir-patel_image

Samir Patel

Stock Details


Company's stock symbol is NASDAQ:EYET

Investors List

j-p-morgan-partners_image

JPMorgan Partners

JPMorgan Partners investment in Series C - Eyetech Pharmaceuticals

bb-biotech-ventures_image

BB Biotech Ventures

BB Biotech Ventures investment in Series C - Eyetech Pharmaceuticals

alta-partners_image

Alta Partners

Alta Partners investment in Series C - Eyetech Pharmaceuticals

schroder-ventures_image

Schroder Ventures

Schroder Ventures investment in Series C - Eyetech Pharmaceuticals

merrill-lynch_image

Merrill Lynch

Merrill Lynch investment in Series C - Eyetech Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Series C - Eyetech Pharmaceuticals

Official Site Inspections

http://www.eyetk.com

  • Host name: tk2-238-28974.vs.sakura.ne.jp
  • IP address: 160.16.125.228
  • Location: Osaka Japan
  • Latitude: 34.6848
  • Longitude: 135.5142
  • Timezone: Asia/Tokyo
  • Postal: 543-0062

Loading ...

More informations about "Eyetech Pharmaceuticals" on Search Engine